Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge

Category: Uncategorized

Gilead’s Hepcludex captures US FDA accelerated approval as pioneering hepatitis D therapy

27/05/2026 Published by vivi

The United States Food and Drug Administration (FDA) has granted formal accelerated approval to Gilead Sciences’ proprietary therapeutic asset, Hepcludex... Read more

Tags: #Global Trends

US FDA extends review window for AstraZeneca’s breast cancer candidate to evaluate supplementary datasets

27/05/2026 Published by vivi

Multinational pharmaceutical flagship AstraZeneca announced on Wednesday that the U.S. Food and Drug Administration (FDA) has formally extended its regulatory... Read more

Category: Uncategorized

Tags: #Global Trends

Eli Lilly deploys nearly $4 billion to acquire three vaccine developers in infectious disease push

27/05/2026 Published by vivi

U.S. pharmaceutical heavyweight Eli Lilly has announced definitive agreements to purchase three clinical-stage vaccine developers in multi-lateral transactions valued at... Read more

Category: Uncategorized

Tags: #M&A

Italian antitrust authority launches probe into Biogen over alleged abuse of market dominance

27/05/2026 Published by vivi

Italy's antitrust regulatory watchdog has formally initiated an official investigation into pharmaceutical manufacturer Biogen Italia and its U.S.-based parent corporation,... Read more

Category: Uncategorized

Tags: #Global Trends

SK bioscience signs technology transfer deal for local chickenpox vaccine production in Colombia

27/05/2026 Published by vivi

South Korean vaccine innovator SK bioscience has finalized a definitive technology transfer and manufacturing agreement with the Colombian government, enabling... Read more

Category: Uncategorized

Tags: #Global Trends

Gilead secures accelerated US FDA nod for hepatitis D therapy following prior manufacturing setbacks

27/05/2026 Published by vivi

More than three years after Gilead Sciences’ targeted hepatitis D virus (HDV) candidate bulevirtide was turned down by the U.S.... Read more

Category: Uncategorized

Tags: #Global Trends

Lantheus evaluates $7 billion buyout offer from Curium amid radiopharmaceutical sector boom

27/05/2026 Published by vivi

The global life sciences ecosystem is registering intensive consolidation momentum as Massachusetts-based Lantheus Holdings considers a multi-billion-dollar takeover proposal from... Read more

Category: Uncategorized

Tags: #M&A

Vietnamese maternal and child market shifts heavily toward origin transparency and authorized distribution

27/05/2026 Published by vivi

The maternal and child product sector in Vietnam is experiencing a profound paradigm shift in consumer behavior. Beyond traditional price... Read more

Category: Uncategorized

Tags: #Vietnam

Vietnam’s Ministry of Health issues new Circular governing free drug programs, strictly prohibiting advertising exploitation

27/05/2026 Published by vivi

The Permanent Vice Minister of Health has officially signed into effect a comprehensive Circular outlining strict regulatory requirements for implementing... Read more

Category: Uncategorized

Tags: #Vietnam

Posts pagination

Previous page Page 1 … Page 24 Page 25 Page 26 … Page 157 Next page

Facebook

Map

Workday: Monday to Friday
Working hours: 8am to 5pm
Address: 8th floor, Hyco 4 building, 205A Nguyen Xi Street, Binh Thanh Ward, HCMC

Please enable JavaScript in your browser to complete this form.

Email

Email *

Get Your Weekly Market Insights Stay informed on Vietnam's market & Healthcare Alliance updates

Category: Uncategorized

Facebook

Map

Online Members